Wang Xiang, Zhang Xiejun, Zhou Qian, Zhou Xiuming, Chen Lei, Huang Guodong, Li Weiping
*Department of Neurosurgery, Clinical College of Anhui Medical University, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital †Shenzhen Key Laboratory of Neurosurgery, Shenzhen, China.
J Craniofac Surg. 2017 Jun;28(4):e329-e330. doi: 10.1097/SCS.0000000000003576.
Intracranial hemangiopericytoma (HPC) is a rare tumor and accounts for 0.4% of all primary central nervous system tumors. However, it has aggressive behavior in growth and infiltration. The importance of diagnosis and treatment between HPC and meningioma cannot be overemphasized. It is rare that HPC arises from the site of benign meningioma resection. And it would be benefitted to take HPC into account when coming across a patient with meningioma "recurrence."
颅内血管外皮细胞瘤（HPC）是一种罕见肿瘤，占所有原发性中枢神经系统肿瘤的0.4%。然而，它在生长和浸润方面具有侵袭性。HPC与脑膜瘤之间诊断和治疗的重要性再怎么强调也不为过。HPC起源于良性脑膜瘤切除部位的情况很罕见。当遇到脑膜瘤“复发”患者时，考虑到HPC会有所帮助。
